Category: PrimeCuts

Clinical Correlations


Primecuts – This Week in the Journals

By Susan Mirabal, MD

Peer Reviewed

With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given the sheer quantity and breadth of literature released on a daily basis.…

Read More

Primecuts – This Week in the Journals

By Scarlett Murphy, MD

Peer Reviewed

Introduction

With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given the sheer quantity and breadth of literature released on a daily basis.…

Read More

Primecuts – This Week in the Journals

By Brianna Knoll, MD

Peer Reviewed

Introduction
With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given the sheer quantity and breadth of literature released on a daily basis.…

Read More

Primecuts – This Week in the Journals

By Nathaniel Siev, MD

Peer Reviewed

With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature. This can quickly become an overwhelming endeavor given the sheer quantity and breadth of literature released on a daily basis.…

Read More

Primecuts – This Week in the Journals

By Gibram Ramos Ortiz, MD

Peer Reviewed

Last week, lawmakers in Congress continued the fight against the opioid epidemic with a bipartisan bill dubbed the SUPPORT for Patients and Communities Act. The bill, which passed in the House of Representatives 393 to 8, offers major policy changes that include the following: creating a grant program for Comprehensive Opioid Recovery Centers, lifting restrictions on medications for opioid addiction, expanding access for first responders to Naloxone, making changes to Medicaid and Medicare to limit the over prescription of opioid painkillers, increasing penalties for drug manufacturers, and improving coordination of federal agencies to stop drugs like fentanyl crossing the border [1].…

Read More